Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $14.00 Average PT from Brokerages

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average […]

Related Keywords

United States ,American ,Piper Sandler ,Sutro Biopharma ,Nicki Vasquez ,Nasdaq ,Deutsche Bank Aktiengesellschaft ,Sutro Biopharma Inc ,Manufacturers Life Insurance Company ,American Century Companies Inc ,Prudential Financial Inc ,American International Group Inc ,Securities Exchange Commission ,Principal Financial Group Inc ,Get Free Report ,Marketbeat Ratings ,Bank Aktiengesellschaft ,Exchange Commission ,Century Companies ,Financial Group ,International Group ,Prudential Financial ,Get Free ,Sutro Biopharma Daily ,Nasdaq Stro ,Castro ,Medical ,Ratings ,Consensus ,